2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Colorectal Cancer

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JH; Ha, SY; Joo, YE; Jung, MW; Kim, HS; Myung, DS; Park, SY; Park, YL	1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Colorectal Cancer

Article	Year
Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells. International journal of oncology, 2019, Volume: 54, Issue:5 Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; fas Receptor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Morpholines; Protein Kinase Inhibitors; Purines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Up-Regulation	2019

Article

Year

Reversine induces cell cycle arrest and apoptosis via upregulation of the Fas and DR5 signaling pathways in human colorectal cancer cells.

International journal of oncology, 2019, Volume: 54, Issue:5

Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; fas Receptor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Morpholines; Protein Kinase Inhibitors; Purines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Up-Regulation

2019